Harvard Bioscience, Inc. to Participate in The Benchmark Healthcare House Call Virtual Conference
Harvard Bioscience, Inc. to Participate in The Benchmark Healthcare House Call Virtual Conference
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET. The Company will also be hosting one-on-one meetings with investors in conjunction with the Conference.
马萨诸塞州霍利斯顿，2024年5月16日（GLOBE NEWSWIRE）——哈佛生物科学公司（纳斯达克股票代码：HBIO）今天宣布，董事长兼首席执行官吉姆·格林和首席财务官詹妮弗·科特将参加2024年5月22日的Benchmark Healthcare House电话会议虚拟会议，并定于美国东部时间上午9点至9点40分进行炉边谈话。该公司还将在会议期间与投资者举行一对一的会议。
To register for the presentation, or to schedule a one-on-one meeting, please visit the Benchmark website at 2024 Benchmark Healthcare House Call Virtual Conference.
如需报名参加演示或安排一对一会议，请在 2024 年 Benchmark Healthcare House 电话会议虚拟会议上访问 Benchmark 网站。